Combination of high-resolution magic angle spinning proton magnetic resonance spectroscopy and microscale genomics to type brain tumor biopsies.

Advancements in the diagnosis and prognosis of brain tumor patients, and thus in their survival and quality of life, can be achieved using biomarkers that facilitate improved tumor typing. We introduce and implement a combinatorial metabolic and molecular approach that applies state-of-the-art, high-resolution magic angle spinning (HRMAS) proton (1H) MRS and gene transcriptome profiling to intact brain tumor biopsies, to identify unique biomarker profiles of brain tumors. Our results show that samples as small as 2 mg can be successfully processed, the HRMAS 1H MRS procedure does not result in mRNA degradation, and minute mRNA amounts yield high-quality genomic data. The MRS and genomic analyses demonstrate that CNS tumors have altered levels of specific 1H MRS metabolites that directly correspond to altered expression of Kennedy pathway genes; and exhibit rapid phospholipid turnover, which coincides with upregulation of cell proliferation genes. The data also suggest Sonic Hedgehog pathway (SHH) dysregulation may play a role in anaplastic ganglioglioma pathogenesis. That a strong correlation is seen between the HRMAS 1H MRS and genomic data cross-validates and further demonstrates the biological relevance of the MRS results. Our combined metabolic/molecular MRS/genomic approach provides insights into the biology of anaplastic ganglioglioma and a new potential tumor typing methodology that could aid neurologists and neurosurgeons to improve the diagnosis, treatment, and ongoing evaluation of brain tumor patients.

[1]  Ex vivo two-dimensional proton nuclear magnetic resonance spectroscopy of smooth muscle tumors: advantages of total correlated spectroscopy over homonuclear J-correlated spectroscopy. , 1994, Cancer research.

[2]  W. Thilly,et al.  Pyruvate utilization, phosphocholine and adenosine triphosphate (ATP) are markers of human breast tumor progression: a 31P- and 13C-nuclear magnetic resonance (NMR) spectroscopy study. , 1995, Cancer research.

[3]  H. Degani,et al.  Variations in energy and phospholipid metabolism in normal and cancer human mammary epithelial cells. , 1996, Anticancer research.

[4]  J. Lacal,et al.  Choline kinase inhibitors as a novel approach for antiproliferative drug design , 1997, Oncogene.

[5]  P. M. Black,et al.  Gangliogliomas in adults , 1997, Cancer.

[6]  Y. Kinoshita,et al.  Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy , 1997, NMR in biomedicine.

[7]  R. Gonzalez,et al.  Quantitative neuropathology by high resolution magic angle spinning proton magnetic resonance spectroscopy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[8]  D G Cory,et al.  Gradient, high‐resolution, magic angle spinning 1H nuclear magnetic resonance spectroscopy of intact cells , 1998, Magnetic resonance in medicine.

[9]  R. Gonzalez,et al.  Correlation of high-resolution magic angle spinning proton magnetic resonance spectroscopy with histopathology of intact human brain tumor specimens. , 1998, Cancer research.

[10]  D. Middleton,et al.  The effect of sample freezing on proton magic‐angle spinning NMR spectra of biological tissue , 1998, Magnetic resonance in medicine.

[11]  S F Keevil,et al.  Absolute metabolite quantification by in vivo NMR spectroscopy: II. A multicentre trial of protocols for in vivo localised proton studies of human brain. , 1998, Magnetic resonance imaging.

[12]  F. Podo Tumour phospholipid metabolism , 1999, NMR in biomedicine.

[13]  D. Cory,et al.  Classification of human liposarcoma and lipoma using ex vivo proton NMR spectroscopy , 1999, Magnetic resonance in medicine.

[14]  J. Lacal,et al.  In vivo antitumor activity of choline kinase inhibitors: a novel target for anticancer drug discovery. , 1999, Cancer research.

[15]  Z. Bhujwalla,et al.  Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. , 1999, Cancer research.

[16]  Leo L. Cheng,et al.  Quantification of microheterogeneity in glioblastoma multiforme with ex vivo high-resolution magic-angle spinning (HRMAS) proton magnetic resonance spectroscopy. , 2000, Neuro-oncology.

[17]  A. R. Tate,et al.  Distinction between normal and renal cell carcinoma kidney cortical biopsy samples using pattern recognition of 1H magic angle spinning (MAS) NMR spectra , 2000, NMR in biomedicine.

[18]  V. Govindaraju,et al.  Proton NMR chemical shifts and coupling constants for brain metabolites , 2000, NMR in biomedicine.

[19]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[20]  V. Tugnoli,et al.  Characterization of lipids from human brain tissues by multinuclear magnetic resonance spectroscopy. , 2001, Biopolymers.

[21]  T. Poggio,et al.  Prediction of central nervous system embryonal tumour outcome based on gene expression , 2002, Nature.

[22]  H. Degani,et al.  Metabolic markers of breast cancer: enhanced choline metabolism and reduced choline-ether-phospholipid synthesis. , 2002, Cancer research.

[23]  Liliana Goumnerova,et al.  Biochemical characterization of pediatric brain tumors by using in vivo and ex vivo magnetic resonance spectroscopy. , 2002, Journal of neurosurgery.

[24]  R. Tibshirani,et al.  Diagnosis of multiple cancer types by shrunken centroids of gene expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[25]  D. Morvan,et al.  Melanoma tumors acquire a new phospholipid metabolism phenotype under cystemustine as revealed by high-resolution magic angle spinning proton nuclear magnetic resonance spectroscopy of intact tumor samples. , 2002, Cancer research.

[26]  P. Black,et al.  Neuroimaging in pediatric brain tumors: Gd-DTPA-enhanced, hemodynamic, and diffusion MR imaging compared with MR spectroscopic imaging. , 2002, AJNR. American journal of neuroradiology.

[27]  T. Golub,et al.  Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. , 2003, Cancer research.

[28]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[29]  John D. Storey,et al.  Statistical significance for genomewide studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[30]  L. Astrakas,et al.  Spectroscopic and perfusion magnetic resonance imaging predictors of progression in pediatric brain tumors , 2004, Cancer.

[31]  R. Tibshirani,et al.  Semi-Supervised Methods to Predict Patient Survival from Gene Expression Data , 2004, PLoS biology.

[32]  L. Astrakas,et al.  Noninvasive Magnetic Resonance Spectroscopic Imaging Biomarkers to Predict the Clinical Grade of Pediatric Brain Tumors , 2004, Clinical Cancer Research.

[33]  Z. Bhujwalla,et al.  Molecular Causes of the Aberrant Choline Phospholipid Metabolism in Breast Cancer , 2004, Cancer Research.

[34]  Julian L. Griffin,et al.  Metabolic profiles of cancer cells , 2004, Nature Reviews Cancer.

[35]  F. Tavani,et al.  A comparison between in vivo and ex vivo HR-MAS 1H MR spectra of a pediatric posterior fossa lesion. , 2005, International journal of molecular medicine.

[36]  George C Tseng,et al.  Tight Clustering: A Resampling‐Based Approach for Identifying Stable and Tight Patterns in Data , 2005, Biometrics.

[37]  R. Kauppinen,et al.  A metabolomics perspective of human brain tumours , 2007, The FEBS journal.

[38]  Loukas G Astrakas,et al.  Predicting survival of children with CNS tumors using proton magnetic resonance spectroscopic imaging biomarkers. , 2007, International journal of oncology.